HIT Interventions to Improve Diabetes and Cardiovascular Medication Adherence

Dr. William Shrank, Harvard Medical School, Brigham and Women's Hospital, discusses his paper and answers questions at the National Press Club in Washington, DC.

Related Videos

Related Content

Advertisement

January 17th 2025

Physiologic Insulin Resensitization Lowers Cost in Patients With Diabetes and Kidney Disease

Zachary Villaverde, BS Roy H. Hinman II, MD Richard M. Grimes, PhD

Patients with diabetes and chronic kidney disease receiving physiologic insulin resensitization had much lower annual costs of care than similar patients not receiving it.

January 14th 2025

Frameworks for Advancing Health Equity: Accessing Ketamine-Assisted Therapy

Giuliana Grossi

Jessica Tracy, head of Growth and Partnerships at Enthea, shares how employers and unions can support mental health and address access barriers to evidence-based ketamine treatments.

January 15th 2025

BCI Shows Promise of Personalized Endocrine Therapy in Breast Cancer

Cameron Santoro

The Breast Cancer Index (BCI) may help identify patients with low-risk breast cancer who could potentially benefit from reduced endocrine therapy, leading to improved quality of life and potentially lower health care costs.

December 26th 2024

Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL

A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.

January 12th 2025

Designing Care for the Underserved Creates Higher-Value Health Solutions

Maggie L. Shaw

In the second half of our interview with Brita Roy, MD, MPH, MHS, NYU Grossman School of Medicine, she discusses effective engagement of minoritized populations in discussion of medical mistrust.

January 9th 2025

AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers

Maggie L. Shaw

In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial intelligence (AI) in cancer care.

Related Content

Advertisement

January 17th 2025

Physiologic Insulin Resensitization Lowers Cost in Patients With Diabetes and Kidney Disease

Zachary Villaverde, BS Roy H. Hinman II, MD Richard M. Grimes, PhD

Patients with diabetes and chronic kidney disease receiving physiologic insulin resensitization had much lower annual costs of care than similar patients not receiving it.

January 14th 2025

Frameworks for Advancing Health Equity: Accessing Ketamine-Assisted Therapy

Giuliana Grossi

Jessica Tracy, head of Growth and Partnerships at Enthea, shares how employers and unions can support mental health and address access barriers to evidence-based ketamine treatments.

January 15th 2025

BCI Shows Promise of Personalized Endocrine Therapy in Breast Cancer

Cameron Santoro

The Breast Cancer Index (BCI) may help identify patients with low-risk breast cancer who could potentially benefit from reduced endocrine therapy, leading to improved quality of life and potentially lower health care costs.

December 26th 2024

Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL

A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.

January 12th 2025

Designing Care for the Underserved Creates Higher-Value Health Solutions

Maggie L. Shaw

In the second half of our interview with Brita Roy, MD, MPH, MHS, NYU Grossman School of Medicine, she discusses effective engagement of minoritized populations in discussion of medical mistrust.

January 9th 2025

AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers

Maggie L. Shaw

In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial intelligence (AI) in cancer care.